Clinical impact of treatment timing for chronic hepatitis C infection: a decision model

E-ISSN： 1365-2893|22|8|630-638

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.8, 2015-08, pp. : 630-638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral treatment of chronic hepatitis C in clinical routine

By Maieron Andreas

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 960-965

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1298-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1298-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 856-865

John Wiley & Sons Inc

Access to resources Recommend Favorite